Daily News Podcast

A hidden bonus for rivaroxaban?

Publish date: September 24, 2018

 

Bleeding from rivaroxaban may help diagnose some GI and GU cancers. Also today, a review by the FDA supports the safety of nuplazid, arthritis is prevalent in older adults with any degree of depression, and growth in overdose deaths is exponential.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Baloxavir, oseltamivir similar for influenza
MDedge Endocrinology
New guidelines on prophylaxis for cancer-related immunosuppresion
MDedge Endocrinology
Review protocols, follow reprocessing guidelines to cut device-related HAIs
MDedge Endocrinology
CDC opens Emergency Operations Center in advance of Hurricane Florence
MDedge Endocrinology
Urine drug screens show improper medication use
MDedge Endocrinology
Alarming rate of diabetes medication discontinuations
MDedge Endocrinology
Task force advises behavioral intervention for obese adults
MDedge Endocrinology
Troubling MRI changes and pediatric hypertension
MDedge Endocrinology
Behavioral intervention in obese adults
MDedge Endocrinology
What you should know about celiac disease
MDedge Endocrinology